Registration rules, dossier documents, timelines, fees, and local representative requirements for interventional devices entering the Dominican market — answered in one place.
October 1, 2026
12
min read
By
BioAccess Editorial Team
**Key takeaways**
- • Yes — registration is mandatory. All medical devices, including non-implantable interventional devices, need a DIGEMAPS registro sanitario before import and sale.
- • No direct foreign filing or import. A DIGEMAPS-licensed Dominican establishment files under the product owner's power of attorney and imports. DIGEMAPS device procedures separate the titular (product owner) from the local representative, and allow co-distributors with the titular's power of attorney.
- • DIGEMAPS publishes a 90-working-day response time per application. Treat it as a service target, not a guaranteed approval date.
- • The real work is the dossier, apostilles, sworn translations, and the local representative.
- • Enforcement is now electronic. VUCE routes import permits through DIGEMAPS — unregistered devices face customs holds.
**Who is this for?**
This guide is for regulatory affairs directors, market access managers, and MedTech executives planning to commercialize interventional medical devices — catheters, guidewires, sheaths, stents, and related products — in the Dominican Republic.
The short answer
Yes. Non-implantable interventional medical devices require a registro sanitario (sanitary registration) from DIGEMAPS — the Dirección General de Medicamentos, Alimentos y Productos Sanitarios — before importation and sale in the Dominican Republic. "Non-implantable" does not exempt a device from registration. The application must be filed by a DIGEMAPS-licensed Dominican establishment acting under a power of attorney from the product owner, and that establishment imports. Customs (DGA) now checks registration electronically through the VUCE single-window system — so shipping first and registering later is not a workable strategy. Plan the filing as manufacturer-funded, be named as titular where DIGEMAPS allows it, and agree change-on-demand clauses with your distributor before launch.
What is DIGEMAPS and what law requires registration?
DIGEMAPS is the Dominican Republic's health-products regulator, operating under the Ministerio de Salud Pública (Ministry of Public Health). It was created by Decreto 82-15 as the authority responsible for the sanitary registration of medicines, foods, and productos sanitarios (health products, including medical devices). The legal framework rests on:
- Ley General de Salud 42-01 — the health framework law covering medicamentos y productos sanitarios
- Decreto 246-06 — the medicines regulation, which DIGEMAPS lists as the legal basis for registering productos sanitarios
- Decreto 82-15 — creates DIGEMAPS within the Ministry of Public Health
- Decreto 1138-03 — governs the licensing (habilitación) of health establishments, including importers and distributors
- DIGEMAPS's published service procedures for productos sanitarios — new registration, change of titular, change of representative and inclusion of a co-distributor
- Proposed, not in force: the Ministry of Public Health's draft Reglamento de Productos Sanitarios y/o Dispositivos Médicos (January 2025)
Under this framework, commercial medical devices may not be imported or marketed without a valid registro sanitario. The registration is product-specific. DIGEMAPS confirms how the certificate names the titular and the local representative.
Do non-implantable interventional devices really need registration?
Yes — with high confidence. The registration obligation applies to medical devices as a category, not by implantability. Interventional devices such as diagnostic and guiding catheters, guidewires, introducer sheaths, angioplasty balloons, and stents all require registration before import and sale, regardless of whether they remain implanted in the patient.
A persistent industry myth holds that device registration in the Dominican Republic is not really enforced — a belief rooted in the pre-2016 era, when many devices entered on importer licensing alone. That era is over (see the enforcement section below). The only carve-outs from the commercial registration requirement are narrow:
- Donations of medical devices (case-specific permit)
- Devices imported for an approved clinical investigation
- Single-patient or institutional emergency use
- Devices in a formal regulatory transition period
**No 'ship first, register later' strategy**
DIGEMAPS will not issue an import authorization for an unregistered device, and customs (DGA) will not release it. Budget registration into your launch timeline from day one.
How are interventional devices classified in the Dominican Republic?
No binding device classification scheme is in force today. DIGEMAPS asks the applicant to declare the device's risk level in the dossier. The Ministry of Public Health's January 2025 draft regulation, which is not in force, would set four classes — I, IIa, IIb and III — following the EU rules. Under the draft, classification depends on intended use, invasiveness, duration of contact, and whether the device contacts the heart, the central circulatory system or the central nervous system — not simply on whether it is implantable.
| Draft class (not in force) | Risk level | Typical interventional examples |
|---|---|---|
| Class I | Low | Non-invasive accessories, manual surgical instruments |
| Class IIa / IIb | Medium | Accessories that do not contact the heart or central circulation, such as some introducers and inflation devices |
| Class III | High | Under draft Rule 6(e), short-term surgically invasive devices that diagnose, monitor or correct a defect of the heart or central circulatory system by direct contact, such as coronary catheters and balloons |
Until a device regulation is enacted, declare the risk level in the dossier and align it with your CE classification. Getting it right at the start matters — it shapes dossier depth and whether clinical evidence summaries are expected.
Can a foreign manufacturer register directly with DIGEMAPS?
No. The application must be filed and endorsed by a DIGEMAPS-licensed Dominican establishment and its technical director, and that establishment imports. DIGEMAPS's device procedures distinguish the titular (the product owner) from the local representative, so a foreign manufacturer may be able to appear as titular with a licensed local company as representative and importer; confirm how the certificate names each party with DIGEMAPS. More than one licensed company can be authorized through DIGEMAPS's co-distributor procedure, with the titular's power of attorney. See titular, representative and co-distributors in the Dominican Republic. The manufacturer appoints the local representative through a Poder de Representación (power of attorney) or Carta de Autorización/Representación issued by the legal manufacturer (not a distributor), which must:
- Identify the manufacturer, the Dominican representative, and the device(s) or families covered
- Expressly authorize the local entity to apply for, maintain and renew the registro and act before DIGEMAPS/MSP
- Be notarized in the country of origin and apostilled — the DR has been a Hague Apostille Convention party since 2009
- Be translated into Spanish by a Dominican intérprete judicial (sworn translator)
The local representative and importer must itself hold the following licenses:
| Requirement | Issued by | Notes |
|---|---|---|
| RNC and incorporation documents | DGII / Cámara de Comercio | Standard legal-entity requirements |
| Registro de Importador | DGA (customs) | Needed to clear goods and operate in VUCE |
| Habilitación / Licencia de Establecimiento as importer-distributor of health products | MSP with DIGEMAPS | Requires premises inspection, a designated responsable técnico (typically a pharmacist), and SOPs |
| Good storage and distribution practices compliance | DIGEMAPS inspection | Verified during habilitación; no separate GMP certificate is required of the importer itself |
| VUCE user registration | DGA / VUCE platform | To request DIGEMAPS import authorizations electronically |
**Titular choice is a commercial decision, not just a regulatory one**
DIGEMAPS publishes separate procedures to change the representative and to change the titular. Both run on a power of attorney from the titular, and a change of titular also needs the original certificate and documents authorizing the transfer — a frequent friction point when the distributor is the titular. Our model for the Dominican Republic: you, the manufacturer, fund the registration and are named as titular where DIGEMAPS allows it, while a licensed Dominican company acts as representative and importer. bioaccess® prepares the dossier and files it together with that representative. Never let the distributor fund the filing, or it can hold the registro hostage. Build change-on-demand clauses into your distribution agreement — reviewed by Dominican counsel, since Dominican distributor-protection law can limit termination — requiring the distributor to sign every document DIGEMAPS needs the moment you ask. bioaccess® does not act as registration holder, representative or importer of record in the Dominican Republic.
What documents does the DIGEMAPS dossier require?
For a non-implantable interventional device (catheters, guidewires), the expediente de registro sanitario typically contains:
Administrative documents
- DIGEMAPS application form (formulario de solicitud de registro sanitario de dispositivos médicos), signed by the titular and the responsable técnico
- Power of attorney / letter of authorization from the legal manufacturer — notarized, apostilled, translated
- Copy of the local representative's establishment registration (habilitación) and RNC
- Certificate of Free Sale (Certificado de Libre Venta) from the competent authority of the country of origin or a reference market where the device is marketed (FDA Certificate to Foreign Government, EU CFS, Health Canada) — must list the device models, be current (issued within 1–2 years), apostilled, and translated
- ISO 13485 certificate of the legal manufacturer (and critical contract manufacturer or sterilizer, if different) from an accredited body — notarized/apostilled copy plus translation
- Evidence of origin-market authorization: FDA 510(k) clearance letter or PMA approval, EC certificate plus Declaration of Conformity
- Proof of payment of government fees
Technical documents
- Device description, intended use, indications and contraindications, catalog numbers, and variants/sizes (families grouped by same intended use, technology, and manufacturer)
- Declared risk level and its rationale
- Materials and components; biocompatibility summary (ISO 10993)
- Manufacturing process summary; sterilization method and validation summary (ISO 11135/11137); packaging and shelf-life justification
- Risk management summary (ISO 14971); safety and performance checklist
- Performance testing summary; clinical evaluation summary (clinical evidence expected for higher-risk devices)
- Labeling and Instructions for Use in Spanish — DIGEMAPS generally accepts multilingual original labeling plus a Spanish IFU, and permits an etiqueta complementaria (Spanish stick-on label with registro number and importer) applied before distribution
- Samples or photographs of the device and packaging (samples may be requested for some classes)
**Apostille and translation rule of thumb**
Every public or notarized foreign document — CFS, POA, notarized ISO/CE/FDA copies, manufacturer declarations — must be apostilled (or consular-legalized if the issuing country is not a Hague party) and translated by a Dominican intérprete judicial. Purely technical documents (test reports, validation summaries, risk management) do not need apostille but must be in Spanish or accompanied by a Spanish translation. China is a Hague Apostille Convention party (since 2023), so Chinese-issued documents can be apostilled rather than consular-legalized.
How long does DIGEMAPS registration take?
DIGEMAPS publishes a response time of 90 working days per registration application. That is a service target, not a guaranteed approval date. Deficiency letters (observaciones) and your responses add time, and the work before filing — apostilles, sworn translations and signing up the local representative — comes on top.
| Phase | Typical duration | Key activities |
|---|---|---|
| Dossier preparation | 2–4 months | Document collection, apostille, sworn translations, gap analysis |
| Submission and admissibility | Part of the DIGEMAPS review | Completeness check by the user-services office; missing items are flagged before the file is accepted |
| Technical review and response | 90 working days published target | Reviewer evaluation, observaciones and responses, sample requests |
| Observaciones rounds | Adds time | Each round of questions and answers extends the overall timeline |
DIGEMAPS also lists 90 working days for a change of representative, a change of titular and the inclusion of a co-distributor. bioaccess® confirms a planning timeline at the proposal stage based on the device and dossier readiness.
What does DIGEMAPS registration cost?
DIGEMAPS government fees are set in DIGEMAPS fee resolutions and change by notice. Confirm the current amounts with DIGEMAPS before budgeting.
The real budget drivers are dossier preparation, apostille and sworn translations, samples, and the regulatory filing itself — and it should be your money, not the distributor's: whoever pays for the registration tends to control it. bioaccess® provides DIGEMAPS registration processing as a quoted, manufacturer-funded service — dossier preparation, sworn translations and agency liaison — filed together with your licensed local representative, with change-on-demand clauses protecting you.
Confirm the validity period of a device registration with DIGEMAPS. Renewal is an affirmative filing obligation: file well before expiry with an updated Certificate of Free Sale, a valid ISO 13485 certificate, current labeling, and a declaration of no changes (or a listing of changes already approved as modifications).
Is there a fast track for FDA-cleared or CE-marked devices?
DIGEMAPS does not operate a formal fast-track or reliance program comparable to some other Latin American regulators — but its review is reliance-based in substance. Registration of an imported device is conditioned on a Certificate of Free Sale plus a QMS certificate (ISO 13485) and the origin-market authorization (FDA clearance/approval, CE certificate, or authorization from another recognized regulator). DIGEMAPS does not independently re-review design verification — the technical dossier receives a summary review.
- A CFS from FDA or an EU authority carries the most weight in practice
- PAHO reference authorities (ANVISA, ANMAT, COFEPRIS, INVIMA, CECMED, ISP Chile) are generally accepted as CFS sources
- DIGEMAPS asks for a Certificate of Free Sale and a manufacturing or quality-system certificate from the country of origin, apostilled or legalized
Practical implication: manufacturers with FDA 510(k) clearance or CE marking already hold the two most valuable documents in the file — the CFS and the origin-market authorization. The remaining work is local: the licensed representative, the apostilled POA, sworn translations, and Spanish labeling.
What happens if you import without registration?
Two eras, one answer. Historically (pre-2016 through roughly 2019), device registration was poorly enforced in the Dominican Republic — many devices entered on importer licensing alone, and registering the trademark with ONAPI was common commercial practice (for brand protection and against parallel imports) but was never a legal sanitary requirement for import. That history is the source of the "registration isn't really enforced" myth.
Today, DIGEMAPS is integrated into VUCE (Ventanilla Única de Comercio Exterior), the foreign-trade single window, and customs (DGA) routes designated tariff lines — HS Chapter 90 instruments, 30.05/30.06 medical consumables, and others — for a DIGEMAPS import authorization (Autorización / No Objeción de Importación). The registro sanitario (or an exemption permit) is checked electronically before release. Unregistered devices now face holds at customs.
- Import permits are tied to the registro — no registration, no import authorization
- Public procurement (PROMESE/CAL, SNS hospitals) and large private networks increasingly require a valid registro sanitario in tenders — now the strongest commercial driver
- Enforcement intensity varies by HS code and how it is flagged in VUCE, but relying on gaps is not a compliance strategy
- Devices imported for a clinical investigation enter under a study-specific DIGEMAPS import permit (tied to ethics and MSP authorization), not under a commercial registro
Frequently Asked Questions
Sources and basis of this article
This article is based on the Dominican regulatory framework as of October 2026: Ley General de Salud 42-01; Decreto 246-06; Decreto 82-15 (official DIGEMAPS text); Decreto 1138-03; DIGEMAPS's published procedures for registration, change of titular, change of representative and inclusion of a co-distributor of productos sanitarios; the Ministry of Public Health's January 2025 draft device regulation (not in force); and regulatory analysis with Mike Legal AI (decision support, not a licensed attorney). Fees, timelines, and resolution-level details change by DIGEMAPS notice — confirm the current fees and requirements with DIGEMAPS or your local representative before budgeting. This article is general information, not legal advice.
BA
bioaccess® · End-to-end medical device registration and market access services across Latin America and the Caribbean, including DIGEMAPS (Dominican Republic), COFEPRIS (Mexico), ANVISA (Brazil), INVIMA (Colombia), and ANMAT (Argentina).
Ready to register your device with DIGEMAPS?
The Dominican Republic is a growing Caribbean device market — but entry runs through DIGEMAPS registration, a licensed local representative, and an apostilled dossier. Our model for the DR: you fund the registration and are named as titular where DIGEMAPS allows it; bioaccess® prepares the dossier and files it together with your licensed local representative (dossier, sworn translations, agency liaison). bioaccess® does not act as registration holder, representative or importer of record in the Dominican Republic. Never let the distributor fund the filing, and lock in change-on-demand clauses before you launch. To start, send your IFUs, your SKU list and your current certificates through our contact page.
Dominican Republic Market Access
Related resources:
- Titular, representative and co-distributors in the Dominican Republic — /blog/dominican-republic-digemaps-titular-representative-co-distributor
- Dominican Republic Market Access — /market-access/dominican-republic-digemaps
- Market Access Services — /market-access
- COFEPRIS medical device registration in Mexico — /blog/cofepris-medical-device-registration-mexico
- Clinical trial insurance in Latin America — /blog/clinical-trial-liability-insurance-latin-america-requirements-by-country